Announcements Trials
Browse Landscape

Phase

Phase 2 17Phase 1 14Phase 3 7Phase 1/2 3Phase NA 2Phase EARLY_PHASE1 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Retinoblastoma 1Ovarian Neoplasms 1Lymphoma 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 5Melphalan 4Isotretinoin 4Etoposide 4Carboplatin 4Vincristine 3Therapeutics 3Radiotherapy 3Cisplatin 3Topotecan 2Stem Cell Transplantation 2Radiotherapy, Image-Guided 2Psychiatric Rehabilitation 2Granulocyte-Macrophage Colony-Stimulating Factor 2Granulocyte Colony-Stimulating Factor 2Doxorubicin 2Dexamethasone 2Calcium Dobesilate 2Busulfan 2Blood Specimen Collection 2Aprepitant 23-Iodobenzylguanidine 2sargramostim 1pegfilgrastim 1humanized 3F8 anti-GD2 monoclonal antibody 1hetrombopag 1etoposide phosphate 1dexamethasone acetate 1dexamethasone 21-phosphate 1Whole-Body Irradiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Neuroblastoma × Topotecan × Clear all
NCT02786719 2020-03-12

SPRING

Baylor College of Medicine

Phase NA Completed
13 enrolled 13 charts
CNS

Neuroblastoma

NCT00526318 2015-07-16

Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma

National Cancer Institute (NCI)

Phase NA Unknown
360 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡